Ruth has over fifteen years of experience conducting market research for a broad range of businesses, including start-up and second stage advanced industry companies with products representing aerospace/defense, healthcare, instrumentation, manufacturing, and IT/internet areas. She began her career working in sales and marketing roles for Pacific Telesis, Qualcomm, and a contract electronics manufacturer, and then switched to research and consulting starting with online start-ups during the emergence of the Internet. More recently, she became certified by the Edward Lowe Foundation as an Economic Gardening Market Researcher, and has served as the lead researcher for the State of Colorado’s Economic Gardening program, in addition to providing research services as part of a specialized program to support emerging technology ventures. As a senior consultant for Foresight Science and Technology since October of 2015, Ruth provides commercialization assistance for technology companies, with a focus on healthcare inventions that receive NIH SBIR funding.
Team Group: Senior Consultant
Terrence Joyce
Terrence J. Joyce, MD, MIP has extensive experience in intellectual property law and its transactions including patent prosecution, portfolio analysis, licensing, and conducting patent searches. He has worked with many organizations assisting them in marketing their intellectual property, performing freedom to operate analyses, and managing their portfolios.
Dr. Joyce is a graduate of Dartmouth Medical School and Franklin Pierce Law Center where he obtained a Master of Intellectual Property, Commerce and Technology degree. Prior to obtaining his degree in intellectual property law, he did residency training in pathology at Yale University and also completed an internship in the Corporate Sponsored Research and Licensing Office of the Massachusetts General Hospital.
He is a member of the mobile Health (mHealth) Regulatory Coalition, an advisory committee of technology leaders and stakeholders, which provides guidance and oversight to the Food and Drug Administration (FDA) regarding the regulation of mobile health technologies.
Dr. Joyce is also the author of several scientific research papers and has served on the editorial board for the Association of University Technology Managers (AUTM), the College of American Pathologists (CAP), and the American Family Physician (AFP). He is the recipient of numerous scientific research awards and fellowships from the American Liver Foundation, the Arthritis Foundation, the Sigma Xi Scientific Research Society, and the National Heart Blood and Lung Institute. In 1994, Dr. Joyce received national recognition for his development of Gene therapy vectors for the treatment of beta-thalassemia and sickle cell disease.
Joseph Janda
Joseph Janda has worked with early stage technology evaluation, IP development and licensing, and university technology start-up companies for over a decade. His experience spans university technology transfer offices at Stony Brook University in New York, George Mason University in Virginia, and for a brief time Oregon Health and Science University focusing on the Knight Cancer Institute. He has been the Director of Innovation & Intellectual Property at Portland State University since 2011.
In these roles he has facilitated the movement of technologies and knowledge from university labs to commercial entities across a broad range of disciplines, and assisted in the formation of several university start-up companies in the fields of cancer and heart disease diagnostics, drug screening, early stage pharma, and remote sensors. As a board observer he has also coached and participated in start-up companies though their first years of operation.
He has also worked as a house painter, veterinary assistant, high school math teacher, biotechnology manufacturing technician, door to door vacuum cleaner salesman, and once spent a summer collecting colorful images of human molars being zapped with a laser.
Fred Rodgers
Mr. Rogers has a 43 year career as an entrepreneur in the technology field. First Fred worked in the computer industry and now for the last twenty years, commercializing university-developed technologies. Currently he is a Senior Advisor to a Wall Street Investment bank, is part of a group working with the Mexican Government to commercialize their university technology, is an advisor to a couple of small technology companies and an Adjunct Professor of Entrepreneurship.
Matan Rapoport
Dr. Matan Rapoport specializes in commercializing biomedical technologies. Through Dr. Rapoport’s experience as senior licensing manager at URVentures, Matan has extensive experience in evaluating biomedical technologies, patent applications, market research & competitive landscape analyzes and negotiating various agreements & licenses with the pharma industry. Matan holds a PhD in Biomedical Sciences from the Hebrew University and an MBA from the University of Rochester.
Richard McCarrick
Mr. Richard (Dick) McCarrick is a technical writer, editor, journalist, and commercialization consultant with over 30 years of experience. Areas of expertise include computer software and web sites, space technology, astronomy, optics, fusion, biofuels. Prior to joining Foresight, Mr. McCarrick spent 16 years at Lotus/IBM, where he worked in a wide variety of technical writing positions, documenting products such as e-mail and messaging, business applications, databases, discussion forums, application development tools, instant messaging, course development, and other collaboration offerings. Mr. McCarrick was responsible for online help, user manuals, system administration guides, system planning, and deployment guides, Web articles, and functional specifications. Other companies Mr. McCarrick worked for include Data General, Data Terminal Systems, and General Dynamics.
Robert Freeze
Mr. Freeze began his career as an analytical microbiologist and chemist before taking on various business roles in the biotechnology industry. In 2011 he began his consulting career as the President of LifeTech Consulting and as a technology commercialization advisor with North Carolina State University, assisting startup biotechnology and life science companies with strategic commercialization efforts. In 2012, Robert worked as an equity research analyst for LifeSci Capital, a leading life science investment bank, where he was responsible for covering publicly traded small- to mid-cap biotechnology companies, and in 2013 also joined Foresight Science & Technology as a senior consultant with a large focus on biotechnology and life science commercialization. In 2014, he joined the business development team at Metabolon, Inc. where he was responsible for leading the expansion of the company’s metabolomics service offerings into clinical trials, and where he is currently focusing on business and market strategy, data analytics and intelligence research. Robert also has experience starting two biotechnology companies – VaporPulse,a nanotechnology company that uses an innovative deposition method for applying anti-microbial coatings to implantable medical devices, and Targeted Therapeutics, Inc., a company developing RNA-based immunotherapeutic cancer vaccines using virus-like particles.
Aaron Chockla
Aaron has worked with multiple start-ups, including a clean-tech venture he co-founded in 2013. Prior to joining Foresight, he worked in various industry sectors, including pharmaceuticals, semiconductors, and renewable energy as a research scientist. He has a broad technical background, with expertise in various life science areas, nanomaterials, semiconductors, and clean energy. Dr. Chockla was recently honored on Forbes Magazine list of 30 Under 30 in energy.
Krysten Oates
Krysten recently received an MSc. in Biomedical Engineering. At Foresight, she provides Spin-up services in addition to client work in technology and market assessment. In the past, Krysten provided programming services for Foresight as well. She was the Project Manager and Lead Developer for Foresight’s T2+2® version 2, the Deputy Project Manager of the Energy Storage Supply Chain Project and led the development of the Energy Storage Supply Chain Portal under contract to the US DOE. Her work for clients focuses on biomedical devices, prostheses and orthoses, advanced energy storage technologies, smart grid, renewable energy, and engines.
James Sitlington
Jim has extensive experience working with small businesses from the start-up phase through the public sale of a companies’ securities. His academic foundation in engineering gives him “an engineer’s mentality” concerning process and product development. His finance and investment banking experience gives him a clear understanding of the viability of an invention and the potential difficulties it may encounter. Most recently, for the five years prior to joining Foresight, Jim was a management consultant working with small businesses. This experience is invaluable in relating to Foresight’s clients.